Portsmouth Hospitals NHS Trust (Funding AgeTech) Non-funding Support
Entity: Portsmouth Hospitals NHS Trust
Category: non-funding entity
Description: Portsmouth Hospitals NHS Trust is working in parnership with the University of Portsmouth's team as partners of the project 'COVID-19 Genomics UK (COG-UK) Consortium' 'COVID-19 Genomics UK (COG-UK) Consortium' is a collaboration between the NHS, Public Health England and other UK public health agencies, the Wellcome Sanger Institute, University of Cambridge and other academic institutions.
1. Project
COVID-19 Genomics UK (COG-UK) Consortium
Research Group: Cardiovascular Epidemiology Unit
Project Description: The COVID-19 Genomics UK (COG-UK) Consortium aims to increase the current capacity for SARS-CoV-2 genetic sequencing in the UK. This sequencing data will be used to understand the epidemiology and spread of the virus, and to monitor and evaluate interventions for COVID-19. SARS-CoV-2 genomic data will be integrated with NHS electronic health records and other existing genomic data to generate insights into susceptibility to COVID-19. From within the DPHPC, Professor John Danesh is a member of the COG-UK Steering Group, Dr Ewan Harrison will serve as the Scientific Project Manager and Dr Michael Chapman will lead the health informatics component.
Contributor:
Dr Samuel Robson, Senior Research Fellow and Bioinformatics Lead at the University of Portsmouth and the Centre for Enzyme Innovation (CEI).
Dr Yann Bourgeois, Lecturer in School of Biological Sciences
Angela Beckett, Specialist Research Technician, Centre for Enzyme Innovation
Category: non-funding entity
Description: Portsmouth Hospitals NHS Trust is working in parnership with the University of Portsmouth's team as partners of the project 'COVID-19 Genomics UK (COG-UK) Consortium' 'COVID-19 Genomics UK (COG-UK) Consortium' is a collaboration between the NHS, Public Health England and other UK public health agencies, the Wellcome Sanger Institute, University of Cambridge and other academic institutions.
1. Project
COVID-19 Genomics UK (COG-UK) Consortium
Research Group: Cardiovascular Epidemiology Unit
Project Description: The COVID-19 Genomics UK (COG-UK) Consortium aims to increase the current capacity for SARS-CoV-2 genetic sequencing in the UK. This sequencing data will be used to understand the epidemiology and spread of the virus, and to monitor and evaluate interventions for COVID-19. SARS-CoV-2 genomic data will be integrated with NHS electronic health records and other existing genomic data to generate insights into susceptibility to COVID-19. From within the DPHPC, Professor John Danesh is a member of the COG-UK Steering Group, Dr Ewan Harrison will serve as the Scientific Project Manager and Dr Michael Chapman will lead the health informatics component.
Contributor:
Dr Samuel Robson, Senior Research Fellow and Bioinformatics Lead at the University of Portsmouth and the Centre for Enzyme Innovation (CEI).
Dr Yann Bourgeois, Lecturer in School of Biological Sciences
Angela Beckett, Specialist Research Technician, Centre for Enzyme Innovation
Technology:
UK AgeTech Funding Bodies
Industry:
UK AgeTech Funding&Support
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
N/A
Register and Claim Ownership